methylprednisolone has been researched along with Cells, Neoplasm Circulating in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuno, Y; Kaku, K; Kamei, S; Kaneko, T; Matsutani, A; Mori, K; Nakai, K; Nishimura, M; Nomiyama, J; Oka, Y; Okafuji, K; Okubo, M; Okuya, S; Takeuchi, Y; Zaitsu, Y | 1 |
| Florensa, L; Guerra, L; Jiménez, S; Malcorra, JJ; Mataix, R; Molero, T; Santana, C; Woessner, S | 1 |
2 other study(ies) available for methylprednisolone and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Clone Cells; Combined Modality Therapy; Drug Resistance, Neoplasm; Fatal Outcome; Female; Graft vs Host Disease; Graft vs Host Reaction; Humans; Immunosuppressive Agents; Leukocyte Transfusion; Male; Methylprednisolone; Neoplastic Cells, Circulating; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Tissue Donors; Transplantation, Homologous | 1996 |
[Splenic lymphoma with circulating hairy lymphocytes lymphoma. Clinical cytological study of 4 patients].
Topics: Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bone Marrow; Combined Modality Therapy; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Humans; Hydrocortisone; Immunophenotyping; Karyotyping; Lymphoma, B-Cell; Male; Methotrexate; Methylprednisolone; Middle Aged; Neoplastic Cells, Circulating; Prednisone; Prognosis; Splenectomy; Splenic Neoplasms; Vincristine | 1995 |